Jessica Powell

Jessica Powell has served as our Chief Development Officer since September 2023, formerly serving as our Vice President, Clinical Operations from June 2022 to September 2023. Prior to joining us, Ms. Powell served in roles of increasing responsibility at Alkahest, Inc., a biotechnology company, from March 2018 to June 2022, most recently serving as its Vice President, Clinical Operations. Before joining Alkahest, Ms. Powell was a Senior Clinical Project Manager at Bioclinica, a contract research organization, from April 2015 to December 2017, where she led Phase 3 Alzheimer’s and Parkinson’s disease clinical trials. From August 2014 to April 2015, Ms. Powell served as a Project Manager at SRI International with a focus on IND enabling preclinical studies. Earlier in her career, Ms. Powell managed a large neuroscience lab from April 2001 to September 2013 at Stanford University with funding from the Howard Hughes Medical Institute. Ms. Powell received a BA in biology from Texas A&M University.